Fujitsu and Southern Tohoku General Hospital start joint research on AI technology for detecting pancreatic cancer from non-contrast CT scans
Retrieved on:
Monday, April 25, 2022
Neutron, Pancreas, Cancer, Laboratory, Neutron capture therapy of cancer, Social, Proton therapy, BNCT, Research, Diagnosis, Pancreatic cancer, Health promotion, ICT, Medicine, Healthy Living, Hospital, Humanities, Patient, SVP, Radiology, FCOM, Technology, QOL, Human body, US, CT, Solution, Sudan Journal of Medical Sciences, AI, National Cancer Center, Neoplasm, Fujitsu, Cyst, Quality of life, Knowledge, Medical imaging
The new AI technology has been trained with data from 300 anonymized CT images of pancreatic cancer patients provided by the Southern Tohoku General Hospital and offers an optimal image analysis method based on the shape of organs and cancer tumors.
Key Points:
- The new AI technology has been trained with data from 300 anonymized CT images of pancreatic cancer patients provided by the Southern Tohoku General Hospital and offers an optimal image analysis method based on the shape of organs and cancer tumors.
- The joint research project represents a new approach to apply AI technology to support medical practitioners in detecting early signs of pancreatic cancer from CT scans.
- Fujitsu and the Southern Tohoku General Hospital will conduct clinical trials within this joint research to further improve the newly developed AI and offer a technology for an early detection of pancreatic cancer that can help to improve the quality of life of each patient.
- Fujitsu will continue research and development on converging technologies(5) that combine AI-powered image analysis technology with Southern Tohoku General Hospital's medical knowledge in pancreatic cancer treatment, with the aim of establishing AI technology able to support the early detection of pancreatic cancer."